Participant Engagement and Symptom Improvement: Aripiprazole Tablets with Sensor for the Treatment of Schizophrenia.
Jeffrey M CochranHui FangChristophe Le GalloTimothy Peters-StricklandJean-Pierre LindenmayerJ Corey Reuteman-FowlerPublished in: Patient preference and adherence (2022)
Participants who completed 3 months of the study and had higher AS engagement experienced significantly greater improvement in their end-of-study clinical assessments versus participants who did not complete 3 months. Improvement may be related to more-consistent medication intake and better engagement with a digital health system.